Critical Reviews in Clinical Laboratory Sciences

Papers
(The TQCC of Critical Reviews in Clinical Laboratory Sciences is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
The COVID-19 pandemic714
Biomarkers associated with COVID-19 disease progression518
COVID-19: from an acute to chronic disease? Potential long-term health consequences212
Current concepts and advances in biomarkers of acute kidney injury73
The COVID-19 pandemic: viral variants and vaccine efficacy61
Effects of age, sex, serostatus, and underlying comorbidities on humoral response post-SARS-CoV-2 Pfizer-BioNTech mRNA vaccination: a systematic review55
A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients51
Preanalytical variables that affect the outcome of cell-free DNA measurements49
Vitamin B12status in health and disease: a critical review. Diagnosis of deficiency and insufficiency – clinical and laboratory pitfalls49
Potential value and impact of data mining and machine learning in clinical diagnostics46
Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites46
Molecular diagnostic assays for COVID-19: an overview42
The laboratory’s role in combating COVID-1936
Recent evolutions of machine learning applications in clinical laboratory medicine25
The molecular structure and biological functions of RNA methylation, with special emphasis on the roles of RNA methylation in autoimmune diseases21
Implementation of patient-based real-time quality control21
Molecular tissue profiling by MALDI imaging: recent progress and applications in cancer research20
Breathing new life into clinical testing and diagnostics: perspectives on volatile biomarkers from breath20
Perspectives on the role of PTEN in diabetic nephropathy: an update20
Nucleic acid-based electrochemical biosensors for rapid clinical diagnosis: advances, challenges, and opportunities19
The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome19
Liquid biopsy with cell free DNA: new horizons for prostate cancer19
Procalcitonin for individualizing antibiotic treatment: an update with a focus on COVID-1918
What the lab can and cannot do: clinical interpretation of drug testing results18
T helper cells in depression: central role of Th17 cells18
The role of kallikreins in inflammatory skin disorders and their potential as therapeutic targets16
The potential impact of salivary peptides in periodontitis15
Choice of SARS-CoV-2 diagnostic test: challenges and key considerations for the future15
CRISPR-based biosensing systems: a way to rapidly diagnose COVID-1915
Clinical applications of extracellular vesicle long RNAs15
Oligoclonal bands: clinical utility and interpretation cues15
Immunologic evaluation and genetic defects of apoptosis in patients with autoimmune lymphoproliferative syndrome (ALPS)14
Multiple biomarker approach for the diagnosis and therapy of rheumatoid arthritis14
Quantifying RNA modifications by mass spectrometry: a novel source of biomarkers in oncology13
Smartphone technology facilitates point-of-care nucleic acid diagnosis: a beginner’s guide13
0.021615982055664